Reporting Emcure Pharmaceuticals Ltd
Share
IFRS
Annual
Quarterly
| 2024 | 2025 | LTM | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|
| Цена акции ао | 1447.1 | 1403.4 | 1403.4 | 1425.25 | -1.52 |
Efficiency
IFRS
Annual
| 2024 | 2025 | LTM | Industry average | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|---|
| ROS, % | 0 | 0 | 0 | |||
| ROCE, % | 0 | 0 | ||||
| Ebit margin, % | 0 | 0 | ||||
| Рентаб EBITDA, % | 0 | 0 | ||||
| Operation Margin, % | 0 | 0 | 0 |
Coefficients
IFRS
Annual
Quarterly
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
